Table 4.
Overview of published Pompe disease screening studies.
| Region | Duration in months | Number of clinics | Number of manually screened patients | Number of suspected patients | Number of confirmed patients | Study |
|---|---|---|---|---|---|---|
| Austria | 1.00 | 5.00 | 104.00 | 19.00 | n/a | Current study |
| Italy | 14.00 | 17.00 | 1,051.00 | 30.00 | 17.00 | (12) |
| Spain | 28.00 | 7.00 | 348.00 | 20.00 | 16.00 | (10) |
| Turkey | 12.00 | 4.00 | 98.00 | 6.00 | 3.00 | (50) |
| Iran | 12.00 | 1.00 | 93.00 | 5.00 | 3.00 | (13) |
| Portugal | 24.00 | 9.00 | 18.00 | 16.00 | 5.00 | (9) |
| Germany, Great Britain | 60.00 | 7.00 | 3,076.00 | 232.00 | 74.00 | (11) |
| Average of other studies | 25.00 | 7.50 | 780.67 | 51.50 | 19.67 | |
| Number needed to screen—suspected | Number needed to screen—confirmed | Discovered patients per month—overall | Discovered patients per month—clinic | Study | ||
| 5.47 | n/a | 104.00 | 20.80 | Current study | ||
| 35.03 | 1.76 | 75.07 | 4.42 | (12) | ||
| 17.40 | 1.25 | 12.43 | 1.78 | (10) | ||
| 16.33 | 2.00 | 8.17 | 2.04 | (50) | ||
| 18.60 | 1.67 | 7.75 | 7.75 | (13) | ||
| 1.13 | 3.20 | 0.75 | 0.08 | (9) | ||
| 13.26 | 3.14 | 51.27 | 7.32 | (11) | ||
| 16.96 | 2.17 | 25.91 | 3.90 | Average of other studies | ||
The italic values indicate the arithmetic averages of the respective column calculated from all studies listed in this table other than the current study.